Ratings of early major depressive disorder symptom change during a brief psychiatric hospitalization

Psychiatric Quarterly

Volumn 76, Issue 1, 2005, Pages 33-48

  Pettit, Jeremy W ^a   Averill, Patricia M ^b   Wassef, Adel A ^b   Gruber, Nelson P ^b   Schneider, Laurie ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Major depressive disorder; Psychiatric inpatients; Treatment

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MENTAL HOSPITAL; MENTAL PATIENT; NURSE; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIST; SELF REPORT; SEX DIFFERENCE; SEX RATIO; SYMPTOM;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; OBSERVER VARIATION; PSYCHOTHERAPY, BRIEF; TIME FACTORS;

EID: 14544269014     PISSN: 00332720     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11089-005-5579-x     Document Type: Article

References (29)

1. World Health Organization: The World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland, World Health Organization, 2002.
2. Leon AC: Measuring onset of antidepressant action in clinical trials: An overview of definitions and methodology. Journal of Clinical Psychiatry 62(suppl 4):12-16, 2001.
3. Stahl SM, Nierenberg AA, Gorman JM: Evidence of early onset of antidepressant effect in randomized controlled trials. Journal of Clinical Psychiatiy 62(suppl 4):17-23, 2001.
4. Berlin I, Lavergne F: Early predictors of two month response with mianserin and selective serotonin reuptake inhibitors and influence of definition of outcome on prediction. European Psychiatiy 13:138-142, 1998.
5. Stassen HH, Angst J, Delini-Stula A: Onset of improvement under fluoxetine and moclobemide. European Psychiatry 13:128-133, 1998.
6. Trivedi MH, Baker SM: Clinical significance of monitoring early symptom change to predict outcome. Journal of Clinical Psychiatry 62(suppl 4):27-33, 2001.
7. Ferguson JM, Mendels J, Schwartz GE: Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression. International Clinical Psychopharmacology 17:45-51, 2002.
8. Worthington J, Fava M, Davidson K, et al: Patterns of improvement in depressive symptoms with fluoxetine treatment. Psychopharmacology Bulletin 31:223-226, 1995.
9. Jonghe FD, Dekker J: Early symptomatic changes in patients treated with antidepressants. European Journal of Psychiatry 13:99-76, 1999.
10. Hoencamp E, Haffmans PMJ, Duivenvoorden H, et al: Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy. Journal of Affective Disorders 31:235-246, 1994.
11. Coryell W, Ziegler VE, Biggs JT: Symptoms as predictors of response to amitriptyline and nortriptyline. Journal of Affective Disorders 2:27-35, 1980.
12. Fava M, Amsterdam JD, Deltito JA, et al: A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Annals of Clinical Psychiatry 10(4):145-150, 1998.
13. Keitner GI, Ryan CE, Miller IW, et al: 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression). American Journal of Psychiatry 148:345-350, 1991.
14. Tedlow J, Fava M, Uebelacker L, et al: Outcome definitions and predictors in depression. Psychotherapy and Psychosomatics 67:266-270, 1998.
15. Lieberman PB, Wiitala SA, Elliot B, et al: Decreasing length of stay: Are there effects on outcomes of psychiatric hospitalization? American Journal of Psychiatry 155:905-909, 1998.
16. Hamilton M: A rating scale for depression. Journal of Neurology, Neurosurgergy, and Psychiatry 23:56-62, 1960.
17. Muller H, Moller HJ: A regression analytical approach to estimate the onset of activity of antidepressants. European Psychiatry 13:134-137, 1998.
18. Piersma HL, Boes JL: Agreement between patient self-report and clinician rating: Concurrence between the BSI and the GAF among psychiatric inpatients. Journal of Clinical Psychology 51(2):153-157, 1995.
19. Joiner TE, Rudd MD, Rajab MH: Agreement between self- and clinician-rated suicidal symptoms in a clinical sample of young adults: Explaining discrepancies. Journal of Consulting and Clinical Psychology 67(2):171-176, 1999.
20. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC, APA, 1994.
21. Woerner MG, Mannuzza S, Kane JM: Anchoring the BPRS: An aid to improved reliability. Psychopharmacology Bulletin 24:112-117, 1988.
22. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychological Reports 10:185-196, 1962.
23. Faustman WO, Overall JE: Brief Psychiatric Rating Scale, in The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, 2nd ed. Edited by Maruish ME. Mahwah, NJ, Lawrence Erlbaum, 1999.
24. Lachar D, Bailey SE, Rhoades HM, et al: Use of BPRS-A percent change scores to identify significant clinical improvement: Accuracy of treatment response classification in acute psychiatric inpatients. Psychology Research 89:258-268, 1999.
25. Murphy DL, Pickar D, Alterman I: A social network approach and the revolving door patient, in Quantitative Techniques for the Evaluation of the Behavior of Psychiatric Patients. Edited by Burdoch EI, Sudilovsky A, Gershon S. New York, Marcel Dekker, 1982.
26. Beck AT, Steer RA, Brown GK: Manual for Beck Depression Inventory-II. San Antonio, TX, Psychological Corporation, 1996.
27. Gibbons RD, Clarke DC, VonAmmon CS, et al: Application of modern psychometric theory in psychiatric research. Journal of Psychiatric Research 19(1):43-55, 1985.
28. Tyrer P: Personality disorders and social functioning, in Measuring Human Problems. Edited by Peck DF, Shapiro CM. New York, Wiley, 1990.
29. Cohen J, Cohen P: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ, Lawrence Earlbaum, 1983.